Floatz logo

61 assets in Polycystic Ovary Syndrome

Therapeutic assets addressing Polycystic Ovary Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Mirabegron
Polycystic Ovary Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)P1C (39)
Red Yeast Rice,Ryr
Polycystic Ovary Syndrome
Sichuan Provincial People's HospitalEarly P1C (39)
Tildacerfont
Polycystic Ovary Syndrome
Spruce BiosciencesP2C (36)
Autologous Conditioned Plasma
Polycystic Ovary Syndrome
Gadjah Mada UniversityN/AD (30)
Beidougen
Polycystic Ovary Syndrome
Peking University Third HospitalN/AD (30)
Dehydroepiandrosterone
Polycystic Ovary Syndrome
University of BirminghamN/AD (30)
Dydrogesterone
Polycystic Ovary Syndrome
Ege UniversityN/AD (30)
Inofolic Combi
Polycystic Ovary Syndrome
Near East University, TurkeyN/AD (30)
Levocarnitine
Polycystic Ovary Syndrome
Mst.Sumyara KhatunN/AD (30)
Synthetic Levothyroxine
Polycystic Ovary Syndrome
Muhamed Ahmed Abdelmoaty Muhamed AlhagrasyN/AD (30)
hrs9531
Polycystic Ovary Syndrome
Fujian Shengdi Pharmaceutical Co., Ltd.P2NR ()
Showing 51 to 61 of 61 assets
PreviousPage 2 of 2Next